Plus TherapeuticsCNSY
13F holders, Q1 2025 (March 31)17holders +6
7new positions
1sold out
$0.95avg. 13F price*
At the end of Q1 2025, 17 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, up 6 from Q4 2024. 7 opened new positions and 1 sold out. The largest holders were HRT Financial LP ($96K), Susquehanna International Group, LLP ($76K) and Geode Capital Management, LLC ($54K).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $256K |
| Exits | 1 | $645K |
All 13F filers, Q4 2024 → Q1 2025: 273,967 shares bought and 562,980 shares sold, net −289,013 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| HRT Financial LP | 0.00% | New | 102,065 | $96K |
| Susquehanna International Group, LLP | 0.00% | New | 80,505 | $76K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.9% | 57,053 | $54K |
| Virtu Financial LLC | 0.00% | New | 40,030 | $38K |
| UBS Group AG | 0.00% | New | 33,437 | $32K |
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $31K |
| Ground Swell Capital, LLC | 0.03% | New | 13,657 | $13K |
| Two Sigma Securities, LLC | 0.00% | Reduce -6.7% | 13,609 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +60.5% | 7,676 | $7K |
| BlackRock, Inc. | 0.00% | No change | 6,960 | $7K |
| Barclays PLC | 0.00% | New | 1,039 | $987 |
| SBI Securities Co., Ltd. | 0.00% | Add +290.9% | 258 | $245 |
| Citigroup Inc. | 0.00% | New | 146 | $139 |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $126 |
| Bank of America Corp. | 0.00% | Add +4.2% | 50 | $48 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.